Premier Alternatives

Benchling

Other Healthcare Technology Systems · San Francisco, CA · Founded 2012 · Privately Held (backing)

Developer of a lab collaboration platform designed to make life science research quick and collaborative. Benchling is based in San Francisco, CA and was founded in 2012. It was valued at $6.1 billion at its later-stage round in Oct 2021, the last priced event on record. It has raised $418 million across 2 recorded rounds; the latest was a $200 million Series E in Apr 2021.

PMV mark · valuation
$6.1B
Oct 2026
Priced at
its later-stage round
Oct 2021
Total raised
$417.9M
Last round
Later Stage VC (Series E)
Apr 2021

Benchling key facts

as of Oct 2026
  • Developer of a lab collaboration platform designed to make life science research quick and collaborative.
  • Benchling is valued at approximately $6.1B as of Oct 2026, set at its later-stage round, Oct 2021; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $417.9M across 2 recorded rounds; the latest was Later Stage VC (Series E) ($200.0M) in Apr 2021.
  • Notable investors include Y Combinator, Andreessen Horowitz, Sequoia Capital, Spark Capital, SV Angel — 44 tracked in total.
  • Benchling has filed 1 Form D with the SEC, most recently Oct 2016 ($7.0M sold to 16 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$6.1B

Valued at $6.1B at its later-stage round, Oct 2021. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Benchling with a free account
  • ·The complete investor list: 44 names
  • ·Watch Benchling: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Benchling funding rounds

2 rounds
Apr 2021Later Stage VC (Series E)$200.0M▮
Apr 2016Early Stage VC$7.0MSEC filing▮
Full funding history →

Benchling valuation

Benchling was valued at $6.1 billion at its later-stage round in Oct 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Benchling raised?

Benchling has raised $418 million in total; 2 of its rounds are on record. The largest on record was a $7 million early-stage round in Apr 2016; the most recent was a $200 million Series E in Apr 2021.

Benchling has filed 1 Form D with the SEC, most recently in Oct 2016 ($7 million sold to 16 investors).

Benchling investors

44 investors are on record for Benchling, including Y Combinator, Andreessen Horowitz, Sequoia Capital and Spark Capital. By type, the record holds 21 venture capital firms, 3 angel investors and 3 private investors. The Series E in Apr 2021 drew 12 investors.

Comparable companies

Comparable other healthcare technology systems names by valuation on PrivateMarketView: Carbon Health ($1.3 billion), Element Biosciences ($1 billion) and Zocdoc ($446 million).

About Benchling

Developer of a lab collaboration platform designed to make life science research quick and collaborative. The company's platform specializes in offering a suite of natively unified applications that accelerate research and development at all levels, and where scientists can design, share, and record experiments as well as share DNA-sequence data in the cloud, enabling researchers to accelerate, measure, and forecast research and development from discovery to bioprocessing, all in one place.

Industry
Other Healthcare Technology Systems
Sector
Healthcare
HQ
San Francisco, CA, United States
Founded
2012
Employees
797
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.